Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitors

• 收藏
• 分享

专利权人:

Incyte Corporation

发明人:

WANG, Xiaozhao,GAN, Pei,HAN, Heeoon,HUANG, Taisheng,MCCAMMANT, Matthew S.,QI, Chao,QIAN, Ding-Quan,WU, Liangxing,YAO, Wenqing,YU, Zhiyong,ZHANG, Fenglei,ZHAO, Le,HE, Chunhong

申请号：

AU2019227607

公开号：

AU2019227607A1

申请日:

2019.02.26

申请国别(地区):

AU

年份:

2020

代理人:

摘要：

This application relates to compounds of Formula (I) or pharmaceutically acceptable salts or stereoisomers thereof, which modulate the activity of adenosine receptors, such as subtypes A2A and A2B receptors, and are useful in the treatment of diseases related to the activity of adenosine receptors including, for example, cancer, inflammatory diseases, cardiovascular diseases, and neurodegenerative diseases.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/